Natixis’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.79M | Sell |
6,068
-112,268
| -95% | -$33.3M | 0.01% | 590 |
|
|
2025
Q4 | $32.3M | Buy |
118,336
+13,862
| +13% | +$3.77M | 0.11% | 125 |
|
|
2025
Q3 | $28.2M | Buy |
104,474
+58,649
| +128% | +$16M | 0.13% | 138 |
|
|
2025
Q2 | $12.6M | Sell |
45,825
-110,837
| -71% | -$30.1M | 0.06% | 211 |
|
|
2025
Q1 | $41.1M | Buy |
156,662
+80,994
| +107% | +$20M | 0.22% | 69 |
|
|
2024
Q4 | $17.6M | Sell |
75,668
-34,671
| -31% | -$7.97M | 0.11% | 148 |
|
|
2024
Q3 | $24.3M | Buy |
110,339
+63,899
| +138% | +$13.2M | 0.14% | 109 |
|
|
2024
Q2 | $9.13M | Sell |
46,440
-74,119
| -61% | -$15.3M | 0.05% | 217 |
|
|
2024
Q1 | $26M | Buy |
+120,559
| New | +$25.3M | 0.13% | 132 |
|
|
2023
Q4 | – | Sell |
-62
| Closed | -$12.4K | – | 1065 |
|
|
2023
Q3 | $12.4K | Sell |
62
-64,207
| -100% | -$12.8M | ﹤0.01% | 887 |
|
|
2023
Q2 | $11.9M | Buy |
+64,269
| New | +$11.9M | 0.1% | 170 |
|
|
2023
Q1 | – | Sell |
-224,333
| Closed | -$37.7M | – | 1018 |
|
|
2022
Q4 | $37.7M | Buy |
224,333
+165,713
| +283% | +$28.8M | 0.21% | 117 |
|
|
2022
Q3 | $10.4M | Buy |
58,620
+29,442
| +101% | +$5.82M | 0.05% | 273 |
|
|
2022
Q2 | $5.96M | Sell |
29,178
-192,328
| -87% | -$40.8M | 0.02% | 405 |
|
|
2022
Q1 | $52.7M | Buy |
221,506
+185,780
| +520% | +$43.6M | 0.18% | 121 |
|
|
2021
Q4 | $8.16M | Sell |
35,726
-139,638
| -80% | -$30.7M | 0.03% | 448 |
|
|
2021
Q3 | $33.9M | Buy |
175,364
+149,035
| +566% | +$30.2M | 0.12% | 160 |
|
|
2021
Q2 | $5.6M | Sell |
26,329
-101,733
| -79% | -$21.5M | 0.02% | 356 |
|
|
2021
Q1 | $26.2M | Buy |
128,062
+89,209
| +230% | +$17.6M | 0.09% | 221 |
|
|
2020
Q4 | $7.07M | Sell |
38,853
-60,359
| -61% | -$10.3M | 0.03% | 454 |
|
|
2020
Q3 | $16.6M | Sell |
99,212
-20,139
| -17% | -$3.39M | 0.12% | 154 |
|
|
2020
Q2 | $19.4M | Sell |
119,351
-5,096
| -4% | -$913K | 0.15% | 125 |
|
|
2020
Q1 | $21.5M | Sell |
124,447
-156,498
| -56% | -$31.1M | 0.17% | 128 |
|
|
2019
Q4 | $56M | Sell |
280,945
-52,705
| -16% | -$10.8M | 0.35% | 79 |
|
|
2019
Q3 | $70.5M | Buy |
+333,650
| New | +$69.7M | 0.45% | 47 |
|
|
2019
Q2 | – | Sell |
-125,049
| Closed | -$20.4M | – | 782 |
|
|
2019
Q1 | $20.4M | Sell |
125,049
-7,823
| -6% | -$1.38M | 0.13% | 166 |
|
|
2018
Q4 | $25M | Sell |
132,872
-124,970
| -48% | -$23.1M | 0.21% | 125 |
|
|
2018
Q3 | $43.9M | Buy |
257,842
+76,724
| +42% | +$12.9M | 0.25% | 100 |
|
|
2018
Q2 | $29.7M | Sell |
181,118
-2,272
| -1% | -$371K | 0.16% | 144 |
|
|
2018
Q1 | $29.7M | Buy |
183,390
+13,877
| +8% | +$2.21M | 0.18% | 129 |
|
|
2017
Q4 | $24.8M | Buy |
169,513
+160,141
| +1,709% | +$22.8M | 0.19% | 128 |
|
|
2017
Q3 | $1.27M | Sell |
9,372
-71,463
| -88% | -$9.03M | 0.01% | 479 |
|
|
2017
Q2 | $10.1M | Buy |
+80,835
| New | +$9.67M | 0.12% | 175 |
|
|
2017
Q1 | – | Sell |
-35,764
| Closed | -$4.13M | – | 946 |
|
|
2016
Q4 | $4.13M | Buy |
35,764
+10,519
| +42% | +$1.17M | 0.04% | 278 |
|
|
2016
Q3 | $2.64M | Buy |
+25,245
| New | +$2.64M | 0.03% | 249 |
|
|
2015
Q3 | – | Sell |
-6,344
| Closed | -$590K | – | 317 |
|
|
2015
Q2 | $590K | Sell |
6,344
-16,757
| -73% | -$1.56M | 0.01% | 242 |
|
|
2015
Q1 | $2.19M | Buy |
23,101
+2,625
| +13% | +$243K | 0.03% | 185 |
|
|
2014
Q4 | $1.81M | Sell |
20,476
-5,524
| -21% | -$468K | 0.03% | 185 |
|
|
2014
Q3 | $2.08M | Buy |
26,000
+3,300
| +15% | +$249K | 0.03% | 201 |
|
|
2014
Q2 | $2.82M | Sell |
22,700
-1,785
| -7% | -$126K | 0.03% | 213 |
|
|
2014
Q1 | $1.81M | Sell |
24,485
-271,115
| -92% | -$20.5M | 0.02% | 255 |
|
|
2013
Q4 | $23.2M | Sell |
295,600
-41,404
| -12% | -$3.24M | 0.2% | 107 |
|
|
2013
Q3 | $24.9M | Buy |
337,004
+295,100
| +704% | +$21.7M | 0.27% | 89 |
|
|
2013
Q2 | $3.18M | Buy |
+41,904
| New | +$2.75M | 0.05% | 201 |
|
Other funds holding CME
VCM
VPM
Natixis's CME Position: Q1 2026 in Review
Natixis reduced its CME Group (CME) stake by 95% in Q1 2026, selling an estimated $33.3M and leaving 6,068 shares worth $1.79M. The position accounts for 0.01% of the portfolio, ranked #590.
Natixis first reported a position in CME in Q2 2013 and has held it in 44 quarters since. The position peaked at $70.5M in Q3 2019. 1,798 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Natixis held 6,068 shares of CME Group worth $1.79M as of Q1 2026.
- Natixis sold 112,268 CME Group shares in Q1 2026, an estimated $33.3M.
- CME Group made up 0.01% of Natixis's portfolio in Q1 2026, its #590 holding.
- Natixis first reported a position in CME Group in Q2 2013 and has held it in 44 quarters since.
- Natixis's CME Group position peaked at $70.5M in Q3 2019.
- 1,798 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.